Press Releases

Recent & Archived News

May 10, 2019

Divya Annamraju, Deputy Director of Strategy for Medical Devices Product Supply at Bayer, Honored as Healthcare Businesswomen's Association Luminary

Divya Annamraju, Deputy Director of Strategy for Medical Devices Product Supply at Bayer, was honored as a Luminary by the Healthcare Businesswomen's Association (HBA) at its annual Woman of the...

Learn more
May 09, 2019

Bayer Invests $150 Million to Build New Cell Culture Technology Center in Berkeley to Spur Innovation of Biotech Therapies

Bayer announced today it will invest $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center that will be used to accelerate...

Learn more
May 01, 2019

Bayer Launches Test Your Cancer Campaign Empowering Patients to See the Real Picture through Genomic Cancer Testing

Bayer announces the launch of Test Your Cancer, a global educational campaign that harnesses the creative power of imagination to help cancer patients better understand that genomic cancer testing...

Learn more
April 30, 2019

U.S. Environmental Protection Agency is Latest Regulatory Agency to Reaffirm that Glyphosate is Not Carcinogenic

Bayer today issued the following statement regarding an interim registration review decision by the U.S. Environmental Protection Agency (EPA) to reapprove glyphosate for use in the U.S. The...

Learn more
April 29, 2019

U.S. FDA accepts New Drug Application and grants Priority Review for darolutamide

Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic...

Learn more
April 24, 2019

Bayer Named to the 2019 Forbes 'America's Best Employers List'

For the third consecutive year, Bayer was named to the Forbes 'America's Best Employers List.' According to the new ranking, Bayer climbed seven spots to No.150 among the Top 500 companies in the...

Learn more
April 11, 2019

Bayer Announces Results of Sub-group Analysis for Vitrakvi® (larotrectinib) in Patients with NTRK Gene Fusion-Positive Metastatic Non-small Cell Lung Cancer (NSCLC)

Bayer today presented subgroup analysis data of patients with non-small cell lung cancer with neurotrophic receptor tyrosine kinase (NTRK) gene fusion treated with Vitrakvi® (larotrectinib).1...

Learn more
April 08, 2019

Bayer welcomes science-based discussion with regulators, researchers and the public: More than 100 Bayer-owned glyphosate safety study reports accessible as Monsanto integration continues

Bayer welcomes a science-based discussion with regulators around the globe, the international research community, as well as with consumers on the safety profile of glyphosate. To that end, all...

Learn more
April 04, 2019

Bayer Only Life Science Company Named as a Most Reputable Company in Biggest-Ever Corporate Reputation Study in U.S.

Bayer U.S. has earned a top ranking in Reputation Institute's 2019 US RepTrak® 100 – the biggest-ever survey measuring the reputation of companies in the country. The results from the 12th...

Learn more
April 04, 2019

At-plant nematode control increases cotton yield potential

University trials across the South show that cotton growers who are battling nematodes can increase their yield and profit with an at-plant nematicide application. Cotton growers know getting a...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.